Dr. Anthony K. Agadzi, MD

Dr. Agadzi practices at Sutter Solano Medical Center in Vallejo, California, part of Sutter Health.

Dr. Agadzi's NPI, 1740323559, was assigned on February 14, 2007. Dr. Agadzi graduated from University Of Minnesota Medical School in 2003. Dr. Agadzi holds California license A89342.

Dr. Agadzi's primary practice is Sutter Solano Medical Center, at 300 Hospital Dr, Vallejo, CA 94589 in Solano County. The practice phone is (707) 554-5280.

Dr. Agadzi's primary practice is Sutter Solano Medical Center in Vallejo, California, part of Sutter Health. Dmand AI also links Dr. Agadzi to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agadzi practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Agadzi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Agadzi is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Agadzi is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Agadzi treats.

CMS data shows 2,490 Medicare services from Dr. Agadzi across 19 procedure codes in 2024, for 812 Medicare patients. Medicare paid $271,454 for them.

CMS counts 812 Medicare patients who saw Dr. Agadzi in 2024. The largest group is 65 to 74, with 346 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 47% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Agadzi's median patient age at 72, with 58% women.

In 2024, Dr. Agadzi wrote 2,463 Medicare Part D claims for 556 patients. 57% of them were for generic drugs. CMS names the drug for 2,371 of them, across 26 drugs with 11 or more claims each, at $334,594 in total drug cost. In 2023, CMS named 2,240 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Agadzi for performance year 2024, reported as part of a group. Dr. Agadzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 344 procedures of cataract surgery by Dr. Agadzi, more than 91% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Agadzi. The most frequent topics are Philippines, White People and Eye Abnormalities. Dr. Agadzi has published most often in J Glaucoma. Dr. Agadzi's most frequent co-authors are Roland Y. Lee, MD, Shan C. Lin, MD and Michael Richard Hee, MD, PhD.

CMS Open Payments shows 78 general payments to Dr. Agadzi from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Alcon Laboratories Inc paid the most, $3,492.

Dmand AI lists 1 award for Dr. Agadzi.

Dr. Agadzi graduated from University Of Minnesota Medical School in 2003. Dr. Agadzi is a member of AAO.

Dr. Agadzi is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.